240 related articles for article (PubMed ID: 12189062)
1. Avoiding a Jekyll-and-Hyde approach to the ethics of clinical research and practice.
Lemmens T; Miller PB
Am J Bioeth; 2002; 2(2):14-7. PubMed ID: 12189062
[No Abstract] [Full Text] [Related]
2. Therapeutic beneficence and placebo controls.
Ackerman TF
Am J Bioeth; 2002; 2(2):21-2. PubMed ID: 12189065
[No Abstract] [Full Text] [Related]
3. Subject indifference and the justification of placebo-controlled trials.
Veatch RM
Am J Bioeth; 2002; 2(2):12-3. PubMed ID: 12189061
[No Abstract] [Full Text] [Related]
4. When argument fails.
Weijer C
Am J Bioeth; 2002; 2(2):10-1. PubMed ID: 12189060
[No Abstract] [Full Text] [Related]
5. What makes placebo-controlled trials unethical?
Miller FG; Brody H
Am J Bioeth; 2002; 2(2):3-9. PubMed ID: 12189059
[TBL] [Abstract][Full Text] [Related]
6. Sham surgery: an ethical analysis.
Miller FG
Am J Bioeth; 2003; 3(4):41-8. PubMed ID: 14744332
[TBL] [Abstract][Full Text] [Related]
7. Placebo controls: scientific and ethical issues.
Kowalski CJ
Am J Bioeth; 2002; 2(2):33-4. PubMed ID: 12189073
[No Abstract] [Full Text] [Related]
8. Therapeutic beneficence and patient recruitment in randomized controlled clinical trials.
Mann H
Am J Bioeth; 2002; 2(2):35-6. PubMed ID: 12189074
[No Abstract] [Full Text] [Related]
9. Clarifying the ethics of clinical research: a path toward avoiding the therapeutic misconception.
Appelbaum PS
Am J Bioeth; 2002; 2(2):22-3. PubMed ID: 12189066
[No Abstract] [Full Text] [Related]
10. Coercion and the SATURN study.
Resnik DB
Am J Bioeth; 2004; 4(1):38-40. PubMed ID: 15035945
[No Abstract] [Full Text] [Related]
11. Control groups in psychosocial intervention research: ethical and methodological issues.
Street LL; Luoma JB
Ethics Behav; 2002; 12(1):1-30. PubMed ID: 12171079
[TBL] [Abstract][Full Text] [Related]
12. The ethics of clinical research in developing countries.
Brunet-Jailly J
IRB; 1999; 21(5):8-11. PubMed ID: 12625349
[No Abstract] [Full Text] [Related]
13. The ethical problems with sham surgery in clinical research.
Macklin R
N Engl J Med; 1999 Sep; 341(13):992-6. PubMed ID: 10498498
[No Abstract] [Full Text] [Related]
14. Exploiting subjects in placebo-controlled trials.
Jecker NS
Am J Bioeth; 2002; 2(2):19-20. PubMed ID: 12189064
[No Abstract] [Full Text] [Related]
15. A step toward truly protecting human subjects: reviewing the review boards.
Albrecht RR
Am J Bioeth; 2004; 4(1):54-5. PubMed ID: 15035952
[No Abstract] [Full Text] [Related]
16. Placebo-controlled trials and the logic of clinical purpose.
Freedman B
IRB; 1990; 12(6):1-6. PubMed ID: 11651265
[No Abstract] [Full Text] [Related]
17. The ethics of single blind trials.
Heckerling PS
IRB; 2005; 27(4):12-6. PubMed ID: 16220629
[No Abstract] [Full Text] [Related]
18. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
Djulbegovic B; Cantor A; Clarke M
Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
[TBL] [Abstract][Full Text] [Related]
19. Failure to conduct a placebo-controlled trial may be unethical.
Cohen PJ
Am J Bioeth; 2002; 2(2):24. PubMed ID: 12189067
[No Abstract] [Full Text] [Related]
20. The use of placebos in clinical trials: responsible research or unethical practice?
Hoffman S
Conn Law Rev; 2001; 33(2):449-501. PubMed ID: 15732201
[No Abstract] [Full Text] [Related]
[Next] [New Search]
